Humana to sell minority stake in Gentiva end-of-life care business for $900M

Humana has agreed to sell its minority interest in Gentiva, a leading provider of hospice and palliative care, for $900 million. This move is part of Humana's ongoing strategy to divest non-core businesses and focus on its growing CenterWell healthcare services, including pharmacy operations. The sale is expected to close in the third quarter of 2026 after regulatory approvals. Proceeds from the sale will be used for general corporate purposes, supporting Humana's shift towards higher-growth healthcare areas.